Rapid Therapeutic Science Laboratories, Inc. (RTSL)
OTCMKTS: RTSL · Delayed Price · USD
0.0015
-0.0007 (-31.82%)
Aug 30, 2024, 2:24 PM EDT - Market closed
RTSL Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| 2022 | 2021 | 2020 | 2020 | 2019 |
Jun '23 Jun 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 |
Revenue | - | - | 0 | 0.14 | 0.01 | - | |
Revenue Growth (YoY) | - | - | -99.62% | 1432.50% | - | - | |
Cost of Revenue | - | - | 0 | 0.03 | 0.01 | - | |
Gross Profit | - | - | 0 | 0.11 | 0 | - | |
Selling, General & Admin | 0.52 | 1.24 | 2.14 | 2.25 | 0.4 | 0.17 | |
Operating Expenses | 0.47 | 1.26 | 2.18 | 2.35 | 0.43 | 0.17 | |
Operating Income | -0.47 | -1.26 | -2.18 | -2.24 | -0.43 | -0.17 | |
Interest Expense | -0.59 | -1.9 | -1.32 | -0.12 | -0.19 | -0.18 | |
Other Non Operating Income (Expenses) | 1.11 | 1.36 | 0.63 | - | - | - | |
EBT Excluding Unusual Items | 0.06 | -1.79 | -2.87 | -2.36 | -0.62 | -0.35 | |
Other Unusual Items | - | - | - | - | - | 0 | |
Pretax Income | 0.06 | -1.79 | -2.87 | -2.36 | -0.62 | -0.35 | |
Net Income | 0.06 | -1.79 | -2.87 | -2.36 | -0.62 | -0.35 | |
Net Income to Common | 0.06 | -1.79 | -2.87 | -2.36 | -0.62 | -0.35 | |
Shares Outstanding (Basic) | 8 | 8 | 8 | 7 | 2 | 0 | |
Shares Outstanding (Diluted) | 8 | 8 | 8 | 7 | 2 | 0 | |
Shares Change (YoY) | 2.64% | 1.54% | 14.77% | 176.87% | 4885.43% | -51.18% | |
EPS (Basic) | 0.01 | -0.23 | -0.38 | -0.36 | -0.26 | -7.24 | |
EPS (Diluted) | 0.01 | -0.23 | -0.38 | -0.36 | -0.26 | -7.24 | |
Free Cash Flow | -0.25 | -1.19 | -2.5 | -1.99 | -0.19 | -0.11 | |
Free Cash Flow Per Share | -0.03 | -0.15 | -0.33 | -0.30 | -0.08 | -2.21 | |
Gross Margin | - | - | 62.55% | 81.04% | 21.71% | - | |
Operating Margin | - | - | -407471.54% | -1600.35% | -4737.97% | - | |
Profit Margin | - | - | -537056.74% | -1687.39% | -6834.27% | - | |
Free Cash Flow Margin | - | - | -468476.03% | -1417.65% | -2084.95% | - | |
EBITDA | -0.44 | -1.24 | -2.14 | -2.13 | -0.4 | -0.15 | |
D&A For EBITDA | 0.02 | 0.02 | 0.03 | 0.11 | 0.04 | 0.02 | |
EBIT | -0.47 | -1.26 | -2.18 | -2.24 | -0.43 | -0.17 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.